New Key Statistics Module, Z-Score and F-Score
NAS:AZN Key Ratios
Market Cap $ M | 221,747.40 |
Enterprise Value $ M | 248,178.55 |
P/E(ttm) | 32.01 |
PE Ratio without NRI | 29.34 |
Forward PE Ratio | 12.08 |
Price/Book | 5.11 |
Price/Sales | 4.10 |
Price/Free Cash Flow | 28.93 |
Price/Owner Earnings | 21.72 |
Payout Ratio % | 0.64 |
Revenue (TTM) $ M | 49,133.00 |
EPS (TTM) $ | 2.07 |
Beneish M-Score | -2.71 |
10-y EBITDA Growth Rate % | 3.50 |
5-y EBITDA Growth Rate % | 6.40 |
y-y EBITDA Growth Rate % | 4.70 |
EV-to-EBIT | 26.41 |
EV-to-EBITDA | 17.62 |
PEG | 4.58 |
Shares Outstanding M | 3,100.61 |
Net Margin (%) | 13.10 |
Operating Margin % | 19.96 |
Pre-tax Margin (%) | 15.75 |
Quick Ratio | 0.69 |
Current Ratio | 0.89 |
ROA % (ttm) | 6.43 |
ROE % (ttm) | 16.87 |
ROIC % (ttm) | 9.53 |
Dividend Yield % | 2.25 |
Altman Z-Score | 2.78 |
AZN Number of Guru Trades
AZN Volume of Guru Trades
Gurus Latest Trades with NAS:AZN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AZN is held by these investors
Total 5
AstraZeneca PLC Insider Transactions
No Available Data
News about NAS:AZN
Total 0- 1